Prospective, Multicentre Study to Evaluate the Thrombectomy System for Stroke: iNedit, iNdeep and iNtercept

NCT05893719 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 175

Last updated 2025-05-16

No results posted yet for this study

Summary

First prospective, single-arm, multicentre study to evaluate the safety and efficacy of the overall stroke thrombectomy system: iNedit, iNdeep and iNtercept in patients with acute ischemic stroke.

Conditions

  • Acute Ischemic Stroke

Interventions

DEVICE

iNedit, iNdeep, iNtercept

Patients to undergo mechanical thrombectomy with iNedit, iNdeep and iNtercept

Sponsors & Collaborators

  • iVascular S.L.U.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-29
Primary Completion
2024-08-17
Completion
2025-02-25

Countries

  • Belgium
  • Germany
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05893719 on ClinicalTrials.gov